Known so far: no new shares from the prospectus covers read · shelf room about $3.9M · not yet read: warrants, converts, options, ATM.
Shelf room
Room todayabout $3.9M
One third of float$3.9M ($11.6M float, Jun 30, 2025)
Sold off it, 12 monthsnothing
How this is worked out
Shelf room about $3.9M on the S-3 of Apr 23, 2026: the baby-shelf rule (public float under $75M) caps sales at one third of the $11.6M public float stated as of Jun 30, 2025, $3.9M, nothing sold off it in the last 12 months. Sources: S-3 Apr 23, 2026, effective May 1, 2026 · public float, as of Jun 30, 2025.
What could become new Cocrystal Pharma (COCP) shares, from its 10-Q, 10-K, S-3 or 424B filings.
Read so far: the cover share count (19.3M shares, +88% from 10.3M on Aug 12, 2025). Not read yet: warrants, convertible notes, options and RSUs and an ATM program.Read them on EDGAR: the latest 10-Q · S-3 shelf filings.
Registrations and share actions on EDGAR (45 filings)
Registration statements, prospectuses, effectiveness notices, information statements and share sales, newest first. Showing the newest 15 of 45. Each links to the filing on EDGAR.
